EMA — authorised 31 January 2011
- Application: EMEA/H/C/001244
- Marketing authorisation holder: ChemGenex Europe SAS
- Local brand name: Tekinex
- Status: withdrawn
🇪🇺 Synribo in European Union
EMA authorised Synribo on 31 January 2011
Marketing authorisation
Synribo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Synribo approved in European Union?
Yes. EMA authorised it on 31 January 2011.
Who is the marketing authorisation holder for Synribo in European Union?
ChemGenex Europe SAS holds the EU marketing authorisation.